VC  Institute for Venture Science

http://www.theinstituteforventurescience.net/





     Office Locations:

2428 Prairie Dunes
Clermont, FL 34711
Phone: 206-708-2458

 

Stages:

  • Early
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    The Institute for Venture Science (IVS) will fund high-risk, non-traditional scientific inquiries that may produce fundamental breakthroughs. IVS identifies the most promising challenges to prevailing paradigms and simultaneously funds multiple research groups worldwide for each selected challenge. The Institute operates on a $1B per year budget, drawn from a permanent endowment. The IVS community represents a combined total of more than 1,000 years of experience in fundamental science ranging across universities, corporations, and governments, in both private and public sectors.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Beverly Rubik PhD Member of the Board
    Frank Costanzo Advisory Panel
    Gerald H. Pollack PhD Executive Director
    Glenn Estrabillo Acting Board Chair

     

    Portfolio companies include:

     

    Recent News: